We accept most major insurance plans and offer self-pay rates, so it is easier to prioritize your health.
This is a question that comes up frequently, and it deserves a nuanced answer
General Safety Profile Based on the preclinical dataset and the limited human exposure data: No prominent signal of hepatic, renal, or hematological toxicity at tested doses No prominent cardiovascular safety flag Pregnancy and lactation as with most research compounds, safety not established Long-term effects not characterized What Clinicians Should Actually Tell Patients For patients asking about 5-amino-1MQ, a reasonable response framework: What the compound is: A research-stage small molecule inhibiting NNMT with promising preclinical fat loss data
Iron deficiency, especially in women, has long been linked with excessive hair shedding
Semaglutide mimics this hormone but lasts far longer in your body, which is why it only requires a once-weekly injection compared to the daily dosing most peptides demand